Back to resultsMetabolic Syndrome and Inflammatory Markers
Primary Purpose
Metabolic Syndrome
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ramadan Fasting
Sponsored by
About this trial
This is an interventional treatment trial for Metabolic Syndrome focused on measuring Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,, Iran
Eligibility Criteria
Inclusion Criteria:
- Males with metabolic syndrome
Exclusion Criteria:
- Conditions with insulin resistance including;
- Type 2 diabetes mellitus,
- Infections,
- Stresses,
- Uremia,
- Acromegaly,
- Glucocorticoid excess,
- Hypertension ,
- Cirrhosis and
- Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
Sites / Locations
Outcomes
Primary Outcome Measures
Measuring inflammatory markers in metabolic syndrome
Secondary Outcome Measures
Full Information
NCT ID
NCT00433082
First Posted
February 8, 2007
Last Updated
February 8, 2007
Sponsor
Free Islamic University of Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT00433082
Brief Title
Metabolic Syndrome and Inflammatory Markers
Official Title
Effect of Fasting With Two Meals on Inflammatory Markers of Metabolic Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
February 2007
Overall Recruitment Status
Completed
Study Start Date
August 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
November 2006 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Free Islamic University of Medical Sciences
4. Oversight
5. Study Description
Brief Summary
The metabolic syndrome has been recognized as a proinflammatory state. It has been shown that many different diets such as Mediterranean diet, DASH diet, Foods with low glycemic index and low saturated fat diet, independent of weight loss, may be effective in improving the metabolic syndrome. Our objective was to evaluate the effect of Ramadan fasting on High-sensitive C-reactive protein (hs-CRP) and fibrinogen levels in metabolic syndrome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome
Keywords
Metabolic syndrome,Ramadan,Fasting,Inflammatory markers,, Iran
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Behavioral
Intervention Name(s)
Ramadan Fasting
Primary Outcome Measure Information:
Title
Measuring inflammatory markers in metabolic syndrome
10. Eligibility
Sex
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Males with metabolic syndrome
Exclusion Criteria:
Conditions with insulin resistance including;
Type 2 diabetes mellitus,
Infections,
Stresses,
Uremia,
Acromegaly,
Glucocorticoid excess,
Hypertension ,
Cirrhosis and
Any addiction or drug therapy and conditions witch cause changes in hs-CRP and fibrinogen levels including infection, trauma, infarction, inflammatory arthritis, various neoplasm and liver diseases.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zahra Vahdat Shariatpanahi, MD
Organizational Affiliation
Islamic Free University of Medical Science
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Metabolic Syndrome and Inflammatory Markers
We'll reach out to this number within 24 hrs